These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

609 related items for PubMed ID: 19686467

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical efficacy of a novel VWF-containing FVIII concentrate, Wilate(®), in the prophylaxis and treatment of bleeding episodes in previously treated haemophilia A patients.
    Klukowska A, Windyga J, Batorova A.
    Thromb Res; 2011 Mar; 127(3):247-53. PubMed ID: 21220152
    [Abstract] [Full Text] [Related]

  • 6. Integrated analysis of safety data from 12 clinical interventional studies of plasma- and albumin-free recombinant factor VIII (rAHF-PFM) in haemophilia A.
    Shapiro AD, Schoenig-Diesing C, Silvati-Fidell L, Wong WY, Romanov V.
    Haemophilia; 2015 Nov; 21(6):791-8. PubMed ID: 26010678
    [Abstract] [Full Text] [Related]

  • 7. Economic and epidemiological modelling of full-length antihaemophilic factor (recombinant), plasma/albumin-free method, in previously treated patients with haemophilia A : comparison with B-domain deleted rFVIII, and value of potential viral transmission reduction due to plasma/albumin-free status.
    Sclar DA, Evans MA, Skaer TL, Robison LM, Chung KC, Poulios NS.
    Drugs R D; 2005 Nov; 6(3):149-56. PubMed ID: 15869318
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment and prevention of acute bleedings in von Willebrand disease--efficacy and safety of Wilate, a new generation von Willebrand factor/factor VIII concentrate.
    Berntorp E, Windyga J, European Wilate Study Group.
    Haemophilia; 2009 Jan; 15(1):122-30. PubMed ID: 19149848
    [Abstract] [Full Text] [Related]

  • 11. Joint outcomes in patients with haemophilia: the importance of adherence to preventive regimens.
    Berntorp E.
    Haemophilia; 2009 Nov; 15(6):1219-27. PubMed ID: 19659939
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics, coagulation factor consumption and clinical efficacy in patients being switched from full-length FVIII treatment to B-domain-deleted r-FVIII and back to full-length FVIII.
    Rea C, Dunkerley A, Sørensen B, Rangarajan S.
    Haemophilia; 2009 Nov; 15(6):1237-42. PubMed ID: 19664015
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B.
    Olasupo OO, Lowe MS, Krishan A, Collins P, Iorio A, Matino D.
    Cochrane Database Syst Rev; 2021 Aug 18; 8(8):CD014201. PubMed ID: 34407214
    [Abstract] [Full Text] [Related]

  • 15. Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A.
    Bonanad S, Núñez R, Poveda JL, Kurnik K, Goldmann G, Andreozzi V, Vandewalle B, Santos S.
    Adv Ther; 2021 Sep 18; 38(9):4872-4884. PubMed ID: 34368918
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A retrospective study of Octaplex in the treatment of bleeding in patients with haemophilia A complicated by inhibitors.
    Berntorp E, Figueiredo S, Futema L, Pock K, Knaub S, Walter O, Trawnicek L, Römisch J.
    Blood Coagul Fibrinolysis; 2010 Sep 18; 21(6):577-83. PubMed ID: 20644466
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparing bleed frequency and factor concentrate use between haemophilia A and B patients.
    Nagel K, Walker I, Decker K, Chan AK, Pai MK.
    Haemophilia; 2011 Nov 18; 17(6):872-4. PubMed ID: 21342368
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.